Labiana Health (XMAD:LAB) ROCE % : -34.84% (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Labiana Health's annualized ROCE % for the quarter that ended in Dec. 2022 was -34.84%.

Labiana Health ROCE % Historical Data

The historical data trend for Labiana Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health ROCE % Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

ROCE %

5.50

0.01

-18.02

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
ROCE %	-	-	-1.05	-34.84

Labiana Health ROCE % Calculation

Labiana Health's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-5.733	/	( ( (68.367 - 30.452)	+	(60.779 - 35.065) )	/ 2 )
	=	-5.733	/	( (37.915	+	25.714)	/ 2 )
	=	-5.733	/	31.8145
	=	-18.02 %

Labiana Health's ROCE % of for the quarter that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2022 )		(Q: Jun. 2022 )		(Q: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2022 )		(Q: Jun. 2022 )		(Q: Dec. 2022 )
	=	-11.068	/	( ( (75.163 - 37.337)	+	(60.779 - 35.065) )	/ 2 )
	=	-11.068	/	( ( 37.826	+	25.714 )	/ 2 )
	=	-11.068	/	31.77
	=	-34.84 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2022) EBIT data.

Labiana Health (XMAD:LAB) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Labiana Health ROCE % Related Terms

Thank you for viewing the detailed overview of Labiana Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.